Clinical trials
Completed Stroke trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
125 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 1 |
| 2003 | 3 |
| 2005 | 4 |
| 2006 | 3 |
| 2008 | 4 |
| 2009 | 5 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 5 |
| 2013 | 7 |
| 2014 | 9 |
| 2015 | 7 |
| 2016 | 9 |
| 2017 | 8 |
| 2018 | 14 |
| 2019 | 5 |
| 2020 | 9 |
| 2021 | 8 |
| 2022 | 3 |
| 2023 | 5 |
| 2024 | 4 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 125 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| KU Leuven | 15 |
| Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 9 |
| University Hospital, Ghent | 7 |
| Vrije Universiteit Brussel | 7 |
| Bayer | 5 |
| Boehringer Ingelheim | 5 |
| Universitaire Ziekenhuizen KU Leuven | 5 |
| Universiteit Antwerpen | 5 |
| Hasselt University | 4 |
| University Ghent | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stroke | 125 |
| Atrial Fibrillation | 17 |
| Ischemic Stroke | 9 |
| Myocardial Infarction | 7 |
| Cardiovascular Diseases | 5 |
| Gait Disorders, Neurologic | 5 |
| Heart Diseases | 5 |
| Ischemic Attack, Transient | 5 |
| Hip Fractures | 4 |
| Ischemia | 4 |
Trials
Showing 1 to 25 of 125. Each trial links to its page on Pharma Observatory.
25 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.